Man Li
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.2%
- Fluorine in Organic Chemistry
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 80
- Nanoparticle-Based Drug Delivery 72
- Oncology 57
- Cancer Immunotherapy and Biomarkers 17
- Cancer Cells and Metastasis 11
- Co-authors
- Qin He (59 shared papers)Zhirong Zhang (49 shared papers)Xiao-Song Xue (10 shared papers)Xun Sun (11 shared papers)Jin‐Pei Cheng (9 shared papers)Tao Gong (10 shared papers)Xian Tang (19 shared papers)Qianwen Yu (17 shared papers)
- Journals
- Journal of Controlled Release (20 papers)Acta Biomaterialia (11 papers)ACS Applied Materials & Interfaces (10 papers)International Journal of Pharmaceutics (7 papers)Nanoscale (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Man Li
341 papers receiving 10.8k citations
Peers
Comparison fields: 5 of 161
- Biomaterials 2.2k
- Pharmaceutical Science 857
- Oncology 1.7k
- Immunology 1.1k
- Drug Discovery 15
Countries citing papers authored by Man Li
This map shows the geographic impact of Man Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Li more than expected).
Fields of papers citing papers by Man Li
This network shows the impact of papers produced by Man Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Li. The network helps show where Man Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 349 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 239 | |
| 2 | 2014 | 229 | |
| 3 | 2017 | 225 | |
| 4 | 2020 | 205 | |
| 5 | 2020 | 190 | |
| 6 | 2016 | 188 | |
| 7 | 2015 | 180 | |
| 8 | 2016 | 166 | |
| 9 | 2017 | 153 | |
| 10 | 2016 | 146 | |
| 11 | 2020 | 138 | |
| 12 | 2014 | 126 | |
| 13 | 2017 | 124 | |
| 14 | 2019 | 122 | |
| 15 | 2017 | 120 | |
| 16 | 2015 | 117 | |
| 17 | 2020 | 113 | |
| 18 | 2019 | 112 | |
| 19 | 2019 | 111 | |
| 20 | 2020 | 110 |
About Man Li
Man Li is a scholar working on Biomaterials, Oncology, Pharmaceutical Science, Immunology and Molecular Biology, having authored 349 papers that have together received 11k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (72 papers), Nanoplatforms for cancer theranostics (24 papers), Cancer Immunotherapy and Biomarkers (17 papers), RNA Interference and Gene Delivery (14 papers), Advanced Drug Delivery Systems (12 papers), Immunotherapy and Immune Responses (12 papers), Cancer Cells and Metastasis (11 papers) and Immune cells in cancer (10 papers). The work is most often cited by research in Biomaterials (2.2k citations), Pharmaceutical Science (857 citations), Oncology (1.7k citations), Immunology (1.1k citations) and Drug Discovery (15 citations). Man Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qin He, Zhirong Zhang, Xiao-Song Xue, Xun Sun, Jin‐Pei Cheng, Tao Gong, Xian Tang, Qianwen Yu, Yang Long and James Lorenzen Boyer. Their work appears in journals such as Journal of Controlled Release, Acta Biomaterialia, ACS Applied Materials & Interfaces, International Journal of Pharmaceutics and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.